Cancer Letters
Volume 286, Issue 1 , Pages 60-68 , 1 December 2009

Hepatitis B virus X gene is implicated in liver carcinogenesis

  • Katsuro Koike

      Affiliations

    • Corresponding Author InformationCorresponding address: Kitasato Institute for Life Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan. Tel.: +81 3 5791 6410; fax: +81 3 5791 6411.

Received 2 May 2008 ,Revised 3 April 2009 ,Accepted 3 April 2009.

References 

  1. Shirakata Y, Koike K. Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential. J. Biol. Chem. 2003;278:22071–22078
  2. Blum HE, Wieland S, Walter E, von Weizsacker F, Offensperger W-B, Moradpour D. Natural course of HBV infection. In:  Koshy R,  Caselmann WH editor. Hepatitis B Virus, Molecular Mechanisms in Disease and Novel Strategies for Therapy. London: Imperial College Press; 1998;p. 75–92
  3. Aldrich CE, Coates L, Wu TT, Newbold J, Tennant BC, Summers JW, et al. In vitro infection of woodchuck hepatocytes with woodchuck hepatitis virus and ground squirrel hepatitis virus. Virology. 1989;172:247–252
  4. Gall PR, Hagelstein J, Kommerell B, Volkmann M, Schranz P, Zentgraf H. In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology. 1994;106:664–673
  5. Gripon P, Diot C, Theze N, Fourel I, Loreal O, Brechot C, et al. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J. Virol. 1988;62:4136–4143
  6. Tuttleman JS, Pugh JC, Summers JW. In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J. Virol. 1986;58:17–25
  7. Schaefer S, Tolle TK, Lottmann S, Gerlich WH. Animal models and experimental systems in hepatitis B virus research. In:  Koshy R,  Caselmann WH editor. Hepatitis B Virus, Molecular Mechanisms in Disease and Novel Strategies for Therapy. London: Imperial College Press; 1998;p. 51–74
  8. Walter E, Keist R, Niederost B, Pult I, Blum HE. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology. 1996;24:1–5
  9. Guidotti LG, Matzke B, Schaller H, Chisari FV. High-level hepatitis B virus replication in transgenic mice. J. Virol. 1995;69:6158–6169
  10. Shirakata Y, Kawada M, Fujiki Y, Sano H, Oda M, Yaginuma K, et al. The x gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn. J. Cancer Res. 1989;80:617–621
  11. Hohne M, Schaefer S, Scifer M, Feitelson MA, Paul D, Gerlich WH. Malignant transformation of immortalized transgenic hepatocyte after transfection with hepatitis B virus DNA. EMBO J. 1990;9:1137–1145
  12. Kim C-M, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature. 1991;351:317–320
  13. Yu DY, Moon HB, Son JK, Jeong S, Yu SL, Yoon H, et al. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J. Hepatol. 1999;31:123–132
  14. Billet O, Grimber G, Levrero M, Seye KA, Briand P, Joulin V. In vivo activity of the hepatitis B virus core promoter: tissue specificity and temporal regulation. J. Virol. 1995;69:5912–5916
  15. Terradillos O, Billet O, Renard CA, Levy R, Molina T, Briand P, et al. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene. 1997;14:395–404
  16. Madden CR, Finegold MJ, Slagle BL. Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J. Virol. 2001;75:3851–3858
  17. Su F, Schneider RJ. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA. 1997;94:8744–8749
  18. Takada S, Shirakata Y, Kaneniwa N, Koike K. Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death. Oncogene. 1999;18:6965–6973
  19. Lu YW, Chen WN. Human hepatitis B virus X protein induces apoptosis in HepG2 cells: role of BH3 domain. Biochem. Biophys. Res. Commun. 2005;338:1551–1556
  20. Kim S, Kim H-Y, Lee S, Kim SW, Sohn S, Kim K, et al. Hepatitis B virus X protein induces perinuclear mitochondrial clustering in microtubule- and dynein-dependent manners. J. Virol. 2007;81:1714–1726
  21. Kobayashi M, Koike K. Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization. Gene. 1984;30:227–232
  22. Aufiero B, Schneider RJ. The hepatitis B virus X-gene product tans-activates both RNA polymerase II and III promoters. EMBO. J. 1990;9:497–504
  23. Koike K, Shirakata Y, Yaginuma K, Arii K, Takada S, Nakamura I, et al. Oncogenic potential of hepatitis B virus. Mol. Biol. Med. 1989;6:151–160
  24. Spandau DF, Lee C-H. Trans-activation of viral enhancers by the hepatitis B virus x protein. J. Virol. 1988;62:427–434
  25. Twu JS, Schloemer RH. Transcriptional trans-activating function of hepatitis B virus. J. Virol. 1987;61:3448–3453
  26. Koike K, Kobayashi M, Gondo M, Hayashi I, Osuga T, Takada S, et al. Hepatitis B virus DNA is frequently found in liver Biopsy samples from hepatitis C virus-infected chronic hepatitis patients. J. Med. Virol. 1998;54:249–255
  27. Pollicino T, Squadrito G, Cerenzia G, Raffa CIG, Craxi A, et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology. 2004;126:102–110
  28. Bréchot C, Hadchonuel M, Scotto J, Degos F, Charnay P, Trepo C, et al. Detection of hepatitis B virus DNA in liver and serum: a direct appraisal of the chronic carrier state. Lancet ii. 1981;765–768
  29. Bréchot C, Hadchouel M, Scotto J, Fonck M, Potet F, Vyas GN, et al. State of hepatitis virus DNA in hepatocyte of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc. Natl. Acad. Sci. USA. 1981;78:3906–3910
  30. Shafritz DA, Shouval D, Shermann HI, Hadziyannis SJ, Kew MC. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. New Engl. J. Med. 1981;305:1067–1073
  31. Yaginuma K, Kobayashi H, Kobayashi M, Morishima T, Matsuyaa K, Koike K. Multiple integration site of hepatitis B virus DNA in hepatocellular carcioma and chronic active hepatitis from children. J. Virol. 1987;61:1808–1813
  32. Koike K, Kobayashi M, Yaginuma K, Shirakata Y. Structure and functions of integrated HBV DNA. In:  Robinson W,  Koike K,  Will H editor. Hepadna Viruses. New York: A. R. Liss; 1987;p. 267
  33. Takada S, Gotoh Y, Hayashi S, Yoshida M, Koike K. Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatitis tissues. J. Virol. 1990;64:822–828
  34. Yang W, Mason WS, Summers J. Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus infected liver. J. Virol. 1996;70:4567–4575
  35. Yang W, Summers J. Integration of hepadna virus DNA in infected livers: evidence for a linear precursor. J. Virol. 1999;73:9710–9717
  36. Marion P, Robinson WS, Rogler CE, Summers J. High molecular weight GSHV-specific DNA in chronically-infected ground squirrel liver. J. Cell Biochem. Suppl. 1982;6:203
  37. Rogler CE, Summers J. Novel form of woodchuck hepatitis virus DNA isolated from chronically infected woodchuck liver nuclei. J. Virol. 1982;44:852–863
  38. Rogler CE, Summers J. Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from a chronically infected liver. J. Virol. 1984;50:832–837
  39. Yaginuma K, Kobayashi M, Yoshida E, Koike K. Hepatitis B virus integration in hepatocellular carcinoma DNA: duplication of cellular flanking sequences at the integration site. Proc. Natl. Acad. Sci. USA. 1985;82:4458–4462
  40. Dejean A, Bougueleret L, Grezeschik KH, Tiollais P. Hepatitis B virus DNA integration in a sequence homologous to verb-A and steroid receptor genes in a hepatocellular carcinoma. Nature. 1986;322:70–72
  41. Wang J, Chenivesse X, Henglein B, Brechot C. Hepatitis B virus integration in a cyclin a gene in a hepatocellular carcinoma. Nature. 1990;343:555–557
  42. Seto E, Yen TSB, Peterlin BM, Ou J. Trans-activation of the human immnodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc. Natl. Acad. Sci. USA. 1988;85:8286–8290
  43. Koike K, Takada S. Biochemistry and function of hepatitis B viurus X protein. Intervirology. 1995;38:89–99
  44. Takada S, Kaneniwa N, Tsuchida N, Koike K. Hepatitis B virus X gene expression is activated by x protein but repressed by p53 tumor suppressor gene product in the transient expression system. Virology. 1996;216:80–89
  45. Yaginuma K, Shirakata Y, Kobayashi M, Koike K. Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc. Natl. Acad. Sci. USA. 1987;84:2678–2682
  46. Mizusawa H, Taira M, Yaginuma K, Kobayashi M, Yoshida E, Koike K. Inversely repeating integrated hepatitis B virus DNA and cellular flanking sequences in the human hepatoma-derived cell line huSP. Proc. Natl. Acad. Sci. USA. 1985;82:208–212
  47. Caselmann WH, Meyer M, Kekule AS, Lauer U, Hofschneider PH. A trans-activator function is generated by integration of hepatitis B virus pres/s sequences in human hepatocellular carcinoma DNA. Proc. Natl. Acad. Sci. USA. 1990;87:2970–2974
  48. von Loringhoven AF, Koch S, Hofschneider PH, Koshy R. Co-transcribed 3′ host sequences augment expression of integrated hepatitis B virus DNA. EMBO J. 1985;4:249–255
  49. Ou JH, Rutter WJ. Hybrid hepatitis B virus-host transcripts in a human hepatoma cell. Proc. Natl. Acad. Sci. USA. 1985;82:83–87
  50. Dejean A, Soningo P, Wain-Hobson S, Tiollais P. Specific hepatitis B virus integration in hepatocellular carcinome DNA through a viral 11-base-pair direct repeat. Proc. Natl. Acad. Sci. USA. 1984;81:5350–5354
  51. Zhou YZ, Butel JS, Li PJ, Finegold MJ, Melnick JL. Integrated state of subgenomic fragments of hepatitis B virus DNA in hepatocellular carcinoma from mainland china. J. Natl. Cancer Inst. 1987;79:223–231
  52. Kekule AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH, Koshy R. The pres2/s region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature. 1990;343:457–461
  53. Matsubara K, Tokino T. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Mol. Biol. Med. 1990;7:243–260
  54. Nagaya T, Nakamura T, Tokino T, Tsurimoto T, Imai M, Mayumi T, et al. The mode of hepatitis B virus DNA integration in chromosome of human hepatocellular carcinoma. Gene Dev. 1987;1:773–782
  55. Takada S, Koike K. Trans-activation function of 3′ truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc. Natl. Acad. Sci. USA. 1990;87:5628–5632
  56. Wollersheim M, Debelka U, Hofschneider PH. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene. 1988;3:545–552
  57. Moriarty AM, Alexander H, Lerner RA, Thornton GB. Antibodies to peptides detect with new-hepatitis B antigens: serological correlation with hepatocellular carcinoma. Science. 1985;227:429–433
  58. Kay A, Mandart E, Trepo C, Galibert F. The HBV X gene expressed in E. coli is recognised by sera from hepatitis patients. EMBO J. 1985;4:1287–1292
  59. Laskowski MJ, Kato I. Protein inhibitors of proteinases. Ann. Rev. Biochem. 1980;49:593–626
  60. Strydom DJ, Joubert FJ. Amino-acid sequence of a weak trypsin inhibitors-B from Dendroaspis-polylepise (Black-mamba). H–S. Z. Physiol. Chem. 1981;362:1377–1384
  61. Wunderer G, Machleidt W, Frotz H. The broad-specificity proteinase inhibitor 5 ii from the sea anemone anemonia sulcata. Method Enzymol. 1981;816–820
  62. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell. 1989;59:1145–1156
  63. Gasson JC, Golde DW, Kaufman SE, Westrbook CA, Hewick RM, Kaufman RJ, et al. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature. 1985;315:768–771
  64. Mckeehan WL, Sakagami Y, Hoshi H, Mckeehan KA. Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors. J. Biol. Chem. 1986;261:5378–5383
  65. Edwards DR, Waterhouse P, Holman ML, Denhardt DT. A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: evidence for inducible and constitutive transcripts. Nucleic. Acid. Res. 1986;14:8863–8878
  66. Rakotomahanina CK, Hilger C, Fink T, Zentgraf H, Schroder CH. Biological activities of a putative truncated hepatitis B virus X gene product fused to a polylysine stretch. Oncogene. 1994;9:2613–2621
  67. Becker SA, Lee TH, Butel JS, Slagle BL. Hepatitis B virus X protein interferes with cellular DNA repair. J. Virol. 1998;72:266–272
  68. Rossner MT. Hepatitis B virus x-gene product: a promiscuous transcriptional activator. J. Med. Virol. 1992;36:101–117
  69. Maguire HF, Hoeffler JP, Siddiqui A. HBV X protein alters the DNA binding specificity of creb and atf-2 by protein–protein interaction. Science. 1991;252:842–844
  70. Natoli G, Avantaggiati ML, Chirillo P, Costanzo A, Artini M, Balsano C, et al. Induction of the DNA-binding activity of c-Jun/c-Fos heterodimers by the hepatitis B virus transactivator pX. Mol. Cell. Biol. 1994;14:989–998
  71. Bouchard MJ, Puro RJ, Wang LH, Schneider RJ. Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in HBV replication. J. Virol. 2003;77:7713–7719
  72. Cross JC, Wen P, Rutter WJ. Transactivation by hepatitis b virus x protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc. Natl. Acad. Sci. USA. 1993;90:8078–8082
  73. Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature. 1993;361:742–745
  74. Natoli G, Avantaggiati ML, Chirillo P, Puri P, Ianni A, Balsano C, et al. Ras- and Raf-dependent activation of c-Jun transcriptional activity by the hepatitis virus transactivator pX. Oncogene. 1994;9:2837–2843
  75. Takada S, Kido H, Fukutomi A, Mori T, Koike K. Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2, as an inhibitor. Oncogene. 1994;9:341–348
  76. Takada S, Koike K. X protein of hepatitis B virus resembles a serine protease inhibitor. Jpn. J. Cancer. Res. 1990;81:1191–1194
  77. Zoulim F, Saputelli J, Seeger C. Woodchuck hepatitis B virus X protein is required for viral infection in vivo. J. Virol. 1994;68:2026–2030
  78. Bouchard MJ, Wang LH, Schneider RJ. Ca2+ signaling by HBx protein in hepatitis B virus replication. Science. 2001;294:2376–2378
  79. Yen TS. Hepadnaviral X protein: review of recent progress. J. Biomed. Sci. 1996;3:20–30
  80. Luber B, Lauer U, Weiss L, Höhne M, Hofschneider PH, Kekulé AS. The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase C. Res. Virol. 1993;144:311–321
  81. Lee YH, Yun Y. HBx protein of hepatitis B virus activates Jak1-STAT signaling. J. Biol. Chem. 1998;273:25510–25515
  82. Waris G, Huh KW, Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol. Cell Biol. 2001;21:7721–7730
  83. Lin Y, Nomura T, Cheong J, Dorjsuren D, Iida K, Murakami S. Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5. J. Biol. Chem. 1997;272:7132–7139
  84. Shamay M, Borak O, Doitsh G, Ben-Dor I, Shaul Y. Hepatitis B virus pX interacts with HVXAP, a PHD finger protein to coactivate transcription. J. Biol. Chem. 2002;277:9982–9988
  85. Shaulsky G, Goldfinger N, Tosky MS, Levine AJ, Rotter V. Nuclear localization is essential for the activity of p53 protein. Oncogene. 1991;6:2055–2065
  86. Takada S, Kaneniwa N, Tsuchida N, Koike K. Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells. Oncogene. 1997;15:1895–1901
  87. Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon M-L, Tiollais P, et al. P53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene. 1998;17:2115–2123
  88. Roulston A, Marcellus R, Branton P. Viruses and apoptosis. Annu. Rev. Microbiol. 1999;53:577–628
  89. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1999;281:1309–1312
  90. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat. Med. 2000;6:513–519
  91. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91:479–489
  92. Zou H, Li Y, Liu X, Wang X. An APAF-1. Cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 1999;274:11549–11556
  93. Wang X. The expanding role of mitochondria in apoptosis. Gene Dev. 2001;15:2922–2933
  94. Koike K. Pathobiology of HBV infection. In:  Diehi AM,  Manns MP,  Hayashi N,  Sauerbruch T editor. Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune. Germany: Springer; 2007;p. 77–88
  95. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. New Engl. J. Med. 1988;319:525–532
  96. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat. Rev. Cancer. 2003;3:276–285
  97. McClain SL, Clippinger AJ, Lizzano R, Bouchard M. Hepatitis B virus replication is associated with an HBx-dependent mitochondrion-regulated increase in cytosolic calcium levels. J. Virol. 2007;81:12061–12065
  98. Keasler VV, Hodgson AJ, Madden CR, Slagle BL. Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J. Virol. 2007;81:2656–2662

PII: S0304-3835(09)00256-0

doi: 10.1016/j.canlet.2009.04.010

Cancer Letters
Volume 286, Issue 1 , Pages 60-68 , 1 December 2009

Article Tools

* Image Usage & Resolution